首页> 外文期刊>Organic process research & development >An Integrated Continuous Flow Micro-Total Ultrafast Process System (mu-TUFPS) for the Synthesis of Celecoxib and Other Cyclooxygenase Inhibitors
【24h】

An Integrated Continuous Flow Micro-Total Ultrafast Process System (mu-TUFPS) for the Synthesis of Celecoxib and Other Cyclooxygenase Inhibitors

机译:一种集成的连续流动微量超快速加工系统(MU-TUFP),用于合成CELECOXIB和其他环氧化酶抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Integrated continuous manufacturing has emerged as a promising device for the rapid manufacturing of active pharmaceutical ingredients (APIs). We herein report a newly designed continuous flow micro-total process system platform for the rapid manufacturing of celecoxib, a selective nonsteroidal anti-inflammatory drug. This approach has been proven generally for the synthesis of several alkyl and aryl substituted pyrazoles. In order to minimize the tedious work-up process of potential reaction intermediates/products, we have developed a continuous flow extraction and separation platform to carry out the entire reaction sequence resulting in a short residence time with good yield. The present process was further extended to gram scale synthesis of the COX-2-related API, viz. celecoxib, in the continuous flow process.
机译:集成的连续制造已成为快速制造活性药物成分(API)的有希望的装置。 我们在此报告了一种新设计的连续流动微量过程系统,可用于塞拉西布的快速制造,一种选择性非甾体抗炎药。 已经证明这种方法通常用于合成几种烷基和芳基取代的吡唑。 为了最小化潜在反应中间体/产品的繁琐后处理过程,我们开发了连续的流动萃取和分离平台,以进行整个反应序列,导致良好的产量率短的停留时间。 本方法进一步扩展为COX-2相关API,VIZ的克拉标量。 Celecoxib,在连续流程过程中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号